Identifying kinematic biomarkers of the dystrophic phenotype in a zebrafish model of Duchenne muscular dystrophy.
- Published in:
- Skeletal Muscle, 2025, v. 15, n. 1, p. 1, doi. 10.1186/s13395-025-00382-6
- By:
- Publication type:
- Article
Works matching IS 20445040 AND DT 2025 AND VI 15 AND IP 1
Results: 17
1
2
Extensive striated muscle damage in a rat model of Duchenne muscular dystrophy with Dmd exons 10–17 duplication.
- Published in:
- Skeletal Muscle, 2025, v. 15, n. 1, p. 1, doi. 10.1186/s13395-025-00386-2
- By:
- Publication type:
- Article
3
Contrasting Becker and Duchenne muscular dystrophy serum biomarker candidates by using data independent acquisition LC-MS/MS.
- Published in:
- Skeletal Muscle, 2025, v. 15, n. 1, p. 1, doi. 10.1186/s13395-025-00385-3
- By:
- Publication type:
- Article
4
OBSCN undergoes extensive alternative splicing during human cardiac and skeletal muscle development.
- Published in:
- Skeletal Muscle, 2025, v. 15, n. 1, p. 1, doi. 10.1186/s13395-025-00374-6
- By:
- Publication type:
- Article
5
ActRII or BMPR ligands inhibit skeletal myoblast differentiation, and BMPs promote heterotopic ossification in skeletal muscles in mice.
- Published in:
- Skeletal Muscle, 2025, v. 15, n. 1, p. 1, doi. 10.1186/s13395-025-00373-7
- By:
- Publication type:
- Article
6
Neuromuscular electrical stimulation training induces myonuclear accretion and hypertrophy in mice without overt signs of muscle damage and regeneration.
- Published in:
- Skeletal Muscle, 2025, v. 15, n. 1, p. 1, doi. 10.1186/s13395-024-00372-0
- By:
- Publication type:
- Article
7
Ephrin-A5 or EphA7 stimulation is anti-proliferative for human rhabdomyosarcoma in vitro.
- Published in:
- Skeletal Muscle, 2025, v. 15, n. 1, p. 1, doi. 10.1186/s13395-025-00384-4
- By:
- Publication type:
- Article
8
GsMTx4-blocked PIEZO1 channel promotes myogenic differentiation and alleviates myofiber damage in Duchenne muscular dystrophy.
- Published in:
- Skeletal Muscle, 2025, v. 15, n. 1, p. 1, doi. 10.1186/s13395-025-00383-5
- By:
- Publication type:
- Article
9
Forskolin treatment enhances muscle regeneration and shows therapeutic potential with limitations in Duchenne muscular dystrophy.
- Published in:
- Skeletal Muscle, 2025, v. 15, n. 1, p. 1, doi. 10.1186/s13395-025-00381-7
- By:
- Publication type:
- Article
10
Pharmacology and macrophage modulation of HPGDS inhibitor PK007 demonstrate reduced disease severity in DMD-affected muscles of the mdx mouse model.
- Published in:
- Skeletal Muscle, 2025, v. 15, n. 1, p. 1, doi. 10.1186/s13395-025-00379-1
- By:
- Publication type:
- Article
11
Correction: OBSCN undergoes extensive alternative splicing during human cardiac and skeletal muscle development.
- Published in:
- Skeletal Muscle, 2025, v. 15, n. 1, p. 1, doi. 10.1186/s13395-025-00380-8
- By:
- Publication type:
- Article
12
Endurance exercise with reduced muscle glycogen content influences substrate utilization and attenuates acute mTORC1- and autophagic signaling in human type I and type II muscle fibers.
- Published in:
- Skeletal Muscle, 2025, v. 15, n. 1, p. 1, doi. 10.1186/s13395-025-00377-3
- By:
- Publication type:
- Article
13
Generation of a novel mouse model of nemaline myopathy due to recurrent NEB exon 55 deletion.
- Published in:
- Skeletal Muscle, 2025, v. 15, n. 1, p. 1, doi. 10.1186/s13395-025-00378-2
- By:
- Publication type:
- Article
14
Zebrafish and cellular models of SELENON-Congenital myopathy exhibit novel embryonic and metabolic phenotypes.
- Published in:
- Skeletal Muscle, 2025, v. 15, n. 1, p. 1, doi. 10.1186/s13395-025-00376-4
- By:
- Publication type:
- Article
15
Dysregulated ATX-LPA and YAP/TAZ signaling in dystrophic Sgcd<sup>−/−</sup> mice with early fibrosis and inflammation.
- Published in:
- Skeletal Muscle, 2025, v. 15, n. 1, p. 1, doi. 10.1186/s13395-025-00375-5
- By:
- Publication type:
- Article
16
Aminoguanidine hemisulfate improves mitochondrial autophagy, oxidative stress, and muscle force in Duchenne muscular dystrophy via the AKT/FOXO1 pathway in mdx mice.
- Published in:
- Skeletal Muscle, 2025, v. 15, n. 1, p. 1, doi. 10.1186/s13395-024-00371-1
- By:
- Publication type:
- Article
17
Sarcolemma resilience and skeletal muscle health require O-mannosylation of dystroglycan.
- Published in:
- Skeletal Muscle, 2025, v. 15, n. 1, p. 1, doi. 10.1186/s13395-024-00370-2
- By:
- Publication type:
- Article